Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
{arrow_up} Back to top

Refixia 3000 IU powder and solvent for solution for injection {equilateral_black_triangle}

Active Ingredient:
nonacog beta pegol
Company:  
Novo Nordisk Limited See contact details
ATC code: 
B02BD04
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) Letters to HCPs HCP Med Info
{arrow_left}
{arrow_right}

Important information for Healthcare Professionals

{pdf_link}

Refixia 3000 IU powder and solvent for injection

{healthcare_pro_orange} For Healthcare Professionals
There has been a printng error on the carton for Refixia 3000® IU powder and solvent for soluton for injecton (nonacog beta pegol) due to missing text. On one side, the currently approved carton is missing the statement of actve substance: ‘Powder: 3 000 IU nonacog beta pegol (approx. 750 IU/ml after reconstitution)’

You are trying to reach document intended for healthcare professionals only.

Are you a healthcare professional?

Log in or sign up to avoid further verifications.

Novo Nordisk Limited
Company image
Address
3 City Place, Beehive Ring Road, Gatwick, West Sussex, RH6 0PA
Telephone
+44 (0)1293 613555
Fax
+44 (0)1293 613535
Customer Care direct line
+44 (0)800 023 2573
Medical Information Direct Line
+44 (0)800 023 2573
Medical Information e-mail
[email protected]
WWW
http://www.novonordisk.co.uk